Dr. Heidi Zhang is the Chief Development Officer at Tune Therapeutics.
A seasoned scientific executive who has led global teams across a range of biotech and pharma companies, including Juno Therapeutics, Genentech, Novartis, and Amgen. Prior to Tune, Heidi was the Vice President of Cell Therapy Product & Analytical Development at Bristol Myers-Squibb.
Her many accomplishments in science and leadership include commercial launches of numerous life-saving medicines – including recent cell therapies Abecma and Breyanzi.